Asia-Pacific Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report and Forecast 2019-2025

Posted April 21, 2022 by Nim0196

Asia-Pacific breast cancer diagnostics market is estimated to grow significantly at a CAGR of around 12.6% during the forecast period.

Get Free Sample link @
Asia-Pacific breast cancer diagnostics market is segmented on the basis of technology and end-user. Based on technology, the market is further classified into mammography, biopsy, position emission tomography/Computed tomography, ultrasound, and others. The mammography segment is projected to hold the largest share in the market. Mammography is a specific medical imaging technique that uses a low-dose x-ray system to see inside the breasts. A mammography exam, called a mammogram, aids in the early detection and diagnosis of breast diseases in women. The introduction of new mammography technologies such as 3D mammography and others are the major driving factor of the breast cancer market. 3D mammography also called breast tomosynthesis and digital breast tomosynthesis (DBT). In this mammography, the multiple images of the breast from different angles are captured into a 3D image set. In this way, 3D breast imaging is similar to computed tomography (CT) imaging in which a series of thin "slices" are assembled together to create a 3D reconstruction of the body. The end-user segment market is further segregated into hospitals and diagnostics centers.
A full report of Asia-Pacific Breast Cancer Diagnostics Market available @
• Market Coverage
• Market number available for – 2019-2025
• Base year- 2019
• Forecast period- 2020-2025
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Asia-Pacific Breast Cancer Diagnostics Market by Technology
o Mammography
o Biopsy
o Ultrasound
o Others (MRI)
Asia-Pacific Breast Cancer Diagnostics Market by End-User
o Hospitals
o Diagnostics Centers
Regional Analysis
o China
o India
o Japan
o Rest of Asia-Pacific
Company Profiles
o Agendia NV
o Becton, Dickinson and Co.
o Danaher Corp.
o General Electric Co.
o Hologic Inc.
o Johnson & Johnson Services Inc.
o Myriad Genetics, Inc.
o NanoString Technologies, Inc.
o Koninklijke Philips N.V.,
o Siemens Healthcare GmbH
The Report Covers
• Comprehensive research methodology of the Asia-Pacific breast cancer diagnostics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Asia-Pacific breast cancer diagnostics market.
• Insights about market determinants which are stimulating the Asia-Pacific breast cancer diagnostics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
For More Customized Data, Request for Report Customization @
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Anurag Tiwari
Country India
Categories Medical
Tags breast cancer diagnostics
Last Updated April 21, 2022